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Abstract
Roughly 25% of individuals 65 years and over hospitalized with heart failure are
readmitted within 30 days after discharge. Elderly individuals identified with heart failure
possess a 5-year mortality approaching 50%. The purpose of this study was to determine if
there is a relationship between Medicare-covered services for care, mortality rates, and
readmission rates for beneficiaries 65 years and over with heart failure. To address this
topic, the chosen approach was retrospective and quantitative. The theoretical foundation
was the Chronic Care Model. The research questions sought to determine if there is a
relationship between the Medicare-covered services for care and mortality rates of patients
65 years and over with heart failure, and whether there is a relationship between Medicarecovered services for care and readmission rates of patients 65 years and over with heart
failure. The study involved Hospital Compare data from CMS for Medicare patients 65
years and over who were seen in hospitals within the United States and diagnosed with
heart failure from 2015 to 2017. Quantitative analyses were conducted through
correlational and multiple regression analysis. Findings indicated statistically significant
relationships of utilization of Medicare and mortality for 2015, 2016, and 2017 and
statistically significant relationships of utilization of Medicare and readmission rates of
individuals 65 years and over with heart failure in 2015 and 2016. It can be concluded that
covariates and a focus on the impact of socioeconomic variables on Medicare beneficiaries
65 years and over with heart failure should be included for future research. Findings may
be used by hospital administrators to create social change by understanding Medicare use
and the needs of older adults.
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Section 1: Foundation of the Study and Literature Review
Heart failure is a widespread and expensive disease, impacting approximately 6.5
million adults in the United States, and is expected to rise to more than 8 million adults by
the year 2030 (Benjamin et al., 2017). Among individuals 65 years and older, the
prevalence of heart failure is expected to rise from 62% in 2012 to 71% in 2030
(Heidenreich et al., 2013). In 2012, the medical costs associated with heart failure were
assessed at around $21 billion (Fitch et al., 2018); these costs are expected to grow to $53
billion by the year 2030. Among individuals 65 and older, medical costs associated with
heart failure are expected to rise approximately 81% to 88%, creating significant monetary
liability for Medicare. The majority of expenses associated with heart failure (80%) are
due to hospital admissions, while about 15% is associated with the care of deteriorating
heart failure (Fitch et al., 2018).
Heart failure is a primary source of mortality in elderly individuals (Butrous &
Hummel, 2016). The Centers for Medicare & Medicaid Services (CMS) reports hospital
specific, 30-day risk standardized readmission and mortality rates publicly for patients of
Medicare admitted with heart failure (Horwitz et al., 2012). These measures are meant to
indicate performance of hospitals on quality of care delivered to patients for the duration
of their hospital stay and after discharge (Horwitz et al., 2012). The Cardiovascular Health
Study (CHS) reported 1-, 5-, and 10-year death rates of 19%, 56%, and 83% after the start
of heart failure (Murad et al., 2015). CHS is a longitudinal cohort study of heart failure in
individuals 65 years and older residing in the US (Murad et al., 2015). Administrative
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records also confirm that once heart failure develops, mortality increases rapidly with age
(Blais et al., 2014).
Heart failure is a leading cause of hospital readmissions for patients with Medicare
in the United States. The Heart Disease and Stroke Statistics Report (2016) from the
American Heart Association estimated that heart failure is responsible for about one
million hospital stays (Mozaffarian et al., 2016). The Affordable Care Act (ACA)
established the Hospital Readmissions Reduction Program (HRRP), which mandated that
the Centers for Medicare and Medicaid Services (CMS) decrease reimbursements to
hospitals that have high readmission rates. This system offered substantial incentives for
both health care professionals and hospitals to minimize readmissions while also
advancing outcomes for patients (McIlvennan et al., 2015). The Healthcare Cost and
Utilization Project (HCUP) (2015) reported a drop in all-cause 30-day readmission rates
for heart failure patients from 25.1% in 2009 to 23.5% in 2013, with cost savings of
approximately $200 million (Bambhroliya, 2018). Additionally, in 2016, MedPAC
reported a decrease in avoidable readmissions due to heart failure from 19.5% in 2010 to
17.0% in 2014 (Borzecki et al., 2016). Due to the increasing prevalence of heart failure in
the United States and the financial consequences associated with high readmission rates, it
is vital to recognize factors contributing to readmissions and create strategies to decrease
readmissions among high-risk groups (Chamberlain et al., 2018).
The aim of this study was to determine if there is a relationship between Medicarecovered services for care, mortality rates, and readmission rates for beneficiaries 65 years
and over with heart failure. This study will allow hospitals to better comprehend the
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utilization of Medicare among heart failure patients 65 years and over and to assess factors
impacting mortality and readmission rates for heart failure Medicare beneficiaries.
Heart failure has an in-hospital mortality rate of 10%, a post-discharge mortality
rate (within one year) of 20%-40%, and a readmission rate (within one month) of 20%25% (Maggioni et al., 2013). Hospital admissions for heart failure are projected to increase
considerably over the next ten years, resulting in a greater burden on the health care
system as costs related to heart failure will also increase (Driscoll et al., 2016). To
effectively treat heart failure, it is necessary to redesign the system of heart failure
treatment in a way that advances evidence-based procedures and establishes unified
organizations of treatment throughout the healthcare system encompassing hospital care,
community care, and primary care (Driscoll et al., 2016).
Section one outlines the research problem, the study purpose, the research
questions and related hypotheses, the theoretical foundation for the study, the nature of the
study, the literature search strategies, the literature review connecting to key variables, the
literature review summary, the definitions of terms utilized in the study, the assumptions
for the study, the scope and delimitations for the study, and the significance of the study.
Problem Statement
Medicare is a health insurance program conducted by the federal government for
individuals over the age of 65, individuals diagnosed with End-Stage Renal Disease, and
younger individuals with disabilities. The study intends to address the research gap
regarding if there is a relationship between Medicare-covered services for care, mortality
rates, and readmission rates for beneficiaries 65 years and over with heart failure.
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One recent study analyzed the National Inpatient Sample from 2001-2009, and
found that in-hospital mortality for Medicare patients 65 years and over dropped from
4.5% in 2001 to 3.3% in 2009. The results suggest that Medicare beneficiaries aged 65
years and over displayed low incidences of heart failure in-hospital mortality. Even though
in-hospital mortality for Medicare beneficiaries has reduced over the past ten years, 30-day
mortality has reduced at a more gradual rate as a result of an increased number of deaths
that transpire after discharge from heart failure stay at the hospital (Chen et al., 2013).
Another study examined claims data among Medicare recipients admitted to the hospital
for heart failure from July 1, 2011, through June 30, 2014. The results indicated that higher
hospital-level 30-day payment episodes were associated with decreased mortality for
patients following heart failure hospitalization (Wadhera et al., 2018).
Even though overall rates for heart failure hospitalization among Medicare
recipients decreased between 1998 and 2008, unexpected readmissions continue to be a
common occurrence, with approximately one in four patients readmitted within 30 days of
discharge. In a study analyzing Medicare heart failure claims from 2009-2012, only 1.4%
of hospitals had attained a 20% decrease in 30-day readmission rates by December of
2012. This percentage was similar to those from reports based on data from the Hospital
Compare database, in which only 2.6% of hospital sites attained a 20% relative decrease
from the periods of July 2006 to June 2009 vs. July 2009 to June 2012. These outcomes
for heart failure patients are reliable, with current information indicating that reductions in
overall readmission rates for fee-for-service Medicare recipients have been minimal,
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despite financial incentives and increased efforts among health systems (Bergethon et al.,
2016).
Purpose of the Study
The purpose of this study was to determine if there is a relationship between
Medicare-covered services for care, mortality rates, and readmission rates for beneficiaries
65 years and over with heart failure. To address this gap, the approach was retrospective,
quantitative, and correlational with the application of multiple regression analysis.
Mortality rates and readmission rates are the dependent variables, and Medicare utilization
is the independent variable. These variables were examined using secondary datasets
(data.medicare.gov/data/hospital-compare and cms.gov/Research-Statistics-Data-andSystems/Statistics-Trends-and-Reports/Chronic-Conditions/CC_Main) in conjunction with
relevant literature to develop an understanding of how Medicare utilization impacts
mortality and readmission rates among heart failure patients 65 years and over.
Research Questions and Hypotheses
RQ1: Is there a relationship between the Medicare-covered services for care and
mortality rates of patients 65 years and over with heart failure?
H1: There is no relationship between Medicare-covered services for care
and mortality of patients 65 years and over with heart failure.
H1: There is a relationship between Medicare-covered services for care and
mortality of patients 65 years and over with heart failure.
RQ2: Is there a relationship between Medicare-covered services for care and
readmission rates of patients 65 years and over with heart failure?
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H2: There is no relationship between the Medicare-covered services for
care and readmission rates of patients 65 years and over with heart failure.
H2: There is a relationship between Medicare-covered services for care and
readmission rates of patients 65 years and over with heart failure.
Theoretical Foundation for the Study
The theoretical foundation for this study was the Chronic Care Model (CCM). This
model is an organizing structure aimed at enhancing the care of persistent illnesses and is
also an exceptional instrument for refining care at both the population and individual level
(Fiandt, 2006). CCM is comprised of six components, including: health systems,
community resources, decision support, patient self-management support, clinical
information systems, and delivery system design (Stellefson et al., 2013). Health systems
work with organizations and mechanisms to encourage high-quality and safe care. Clinical
information systems work to manage population and patient data. Patient self-management
support aims to allow patients to supervise their health care and health. The community
resources component of CCM is meant to mobilize patients’ resources. Finally, the
delivery system design works with self-management support and clinical care, which also
includes team care (Stellefson et al., 2013).
Heart failure poses a substantial challenge for health care systems. The demands of
heart failure-associated health care and costs are expected to increase (Lesyuk et al., 2018).
The CCM provides an improved method of providing care for patients with heart failure.
Chronic care management dramatically decreases mortality in heart failure patients
(Lorenzini et al., 2016) and has a positive impact on shorter hospitalizations and better
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quality of life (Drewes et al., 2012). The CCM method is potentially advantageous for the
supervision of patients with heart failure; however, studies have found mixed (Ballo et al.,
2018).
Nature of the Study
Quantitative research includes the use of mathematical, statistical, and
computational tools to derive outcomes (McLeod, 2019). This study was correlational with
a quantitative focus through the use of multiple regression analysis. Previous studies have
focused on mortality and readmission rates of patients with pneumonia, heart failure, and
acute myocardial infarction. One such study utilized correlation analysis to examine the
relationship between hospital mortality rates and readmission rates (Krumholz et al.,
2013). Another recent study analyzed readmission and mortality rates of heart failure
patients using a multi-level logistic model that allowed the researchers to disentangle
hospital- and patient-level covariates (Roshanghalb et al., 2019).
Literature Search Strategy and Keywords
A variety of resources were used in the literature search. These resources included:
the databases ScienceDirect, PubMed, Medline, and Academic Search Complete; Walden
University’s library; and Google Scholar. The literature search was conducted by
searching keywords in ScienceDirect, PubMed, Medline, and Academic Search Complete.
Keywords included: Medicare, mortality rates, geriatric, elderly, heart failure,
readmission rates, the Chronic Care Model, 30-day readmission, and insurance. This
literature search was limited to journal articles published within the last five years; older
articles were utilized only when more current data was not available.
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Literature Review
The literature review focused on critical variables, including: Medicare utilization
and heart failure outcomes, mortality rates of heart failure patients 65 years and over,
readmission rates of heart failure patients 65 years and over, financial burden of heart
failure on patients, impact of patient age on heart failure patients, and CCM alignment
with heart failure. Heart failure mortality rates are important given that CMS (via the
obligatory Hospital Value-based Purchasing, HVBP, system) monetarily penalizes or
rewards institutions based on patient mortality rates (Wadhera et al., 2018). Similarly,
heart failure readmission rates are important given that the Hospital Readmission
Reduction Program (HRRP) requires CMS to financially penalize hospitals if heart failure
readmission rates are higher than expected (McIlvennan et al., 2015).
Literature Review Related to Key Variables
The Link between Medicare Utilization and Heart Failure Outcomes
In contrast to younger patients, older heart failure patients are usually cared for by
general physicians rather than cardiologists. Previous research demonstrates that general
physicians recommend fewer follow-up procedures and fewer potentially effective
medications compared to cardiologists (Berliner & Bauersachs, 2018).
The management and diagnosis of heart failure are usually more challenging in
older individuals due to comorbidity, frailty, cognitive impairment, and polypharmacy.
Complete consideration of these geriatric issues is crucial for patient-centered
management, prognosis determination, and enhancement of overall clinical results in
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elderly heart failure adults (Butrous & Hummel, 2016). One recent study found that
approximately 60% of older adults with heart failure possessed three or more
comorbidities, while just 2.5% did not possess any related comorbidities (Murad et al.,
2015). Hypertension was the most frequent comorbidity, at approximately 82%
occurrence, trailed by coronary heart disease, at around 60% occurrence. Additional
cardiac comorbidities include cardiac valvular disease, arrhythmias, and peripheral
vascular disease. Common non-cardiac comorbidities include diabetes mellitus,
malnutrition, sleep apnea, cognitive dysfunction, chronic kidney disease, anemia,
depression, and arthritis. Not surprisingly, some comorbid illnesses are associated with
higher mortality in elderly heart failure individuals, including: depression, diabetes
mellitus, chronic kidney disease, and cerebrovascular disease, with comorbid
cerebrovascular disease having the greatest mortality rate (Murad et al., 2015). In recent
years, the prevalence of comorbid disorders among elderly heart failure patients has
increased and, given that pharmacotherapy is a common treatment for many of these
disorders, polypharmacy is a common issue (Murad et al., 2015).
Reduced functional capability is typical in elderly heart failure patients,
particularly after admission to the hospital. An unbiased assessment of functional
capability can offer prognostic importance in elderly heart failure patients. Symptomlimited cardiopulmonary exercise testing (CPET) is considered the gold-standard modality
since it determines exercise intolerance and offers numerous independent forecasters of
heart failure patients’ survival odds (e.g., the ventilatory equivalent ratio for carbon
dioxide and peak oxygen consumption) (Butrous & Hummel, 2016). Unfortunately, CPET
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is costly, not available universally, time-consuming, and can be difficult for older patients
to complete (Butrous & Hummel, 2016).
One study found that Medicare insured the majority (90.9%) of heart failure
patients aged 65 years and older, and that individuals with Medicare had considerably
shorter durations of stay for heart failure hospitalizations; this trend was not seen among
individuals possessing other insurance coverages (Chen et al., 2013). In-hospital mortality
for Medicare individuals with heart failure dropped from 4.5% in 2001 to 3.3% in 2009.
Significant decreases in in-hospital mortality were also detected for adults aged 65 - 74
years and 75 years or older. Individuals possessing self-pay coverage, private insurance,
Medicaid, and Medicare had substantial drops in in-hospital mortality. Utilizing a
nationwide all-payer database of institution discharges within the US, the general
nationwide hospitalization rate of heart failure fell by a comparative 26.9% from 20012009. This drop is comparable in scale to the 29.5% drop for hospitalization rates for heart
failure detected in the population with Medicare from 1998 to 2008. Adults of standard
Medicare age (greater than or equal to 65 years old) had statistically significant decreases
over time in duration of stay during the period of the study. Elderly patients usually have
several comorbidities, and thus possibly additional chances to lessen length of stay (LOS)
through more rigorous utilization of expert nursing accommodations or more referrals to
hospice care, both of which have grown in the population with Medicare over the past ten
years. Even though in-hospital mortality has reduced throughout the past ten years
amongst Medicare beneficiaries, 30-day mortality has gradually reduced as a result of an
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increased amount of deaths that transpire the following discharge from heart failure
hospitalization (Chen et al., 2013).
A previous examination of Medicare claims data discovered that, of the individuals
admitted for heart failure, an outpatient visit did not occur for approximately 52% of
individuals (Driscoll et al., 2016). Heart failure medical procedures require prompt checkup seven to ten days after discharge (Driscoll et al., 2016). Most analyses of information
from The Longitudinal Health and Retirement Study have reported that insurance coverage
in near-elderly individuals is associated with a slower rate of health deterioration and
reduced mortality (Woolhandler & Himmelstein, 2017). Similarly, two US studies and one
Canadian study compared mortality trends across matched locations without and with
coverage expansions and reported that greater coverage was associated with lower
mortality (Woolhandler & Himmelstein, 2017).
Advanced heart failure patients, or Stage D heart failure, have evident heart failure
indicators at rest despite optimum medical supervision, as described by the American
College of Cardiology/the American Heart Association (Yim et al., 2017). In addition,
these patients have higher one-year mortality rates (approximately 50%). Consequently,
the American College of Cardiology/the American Heart Association standards
recommend that healthcare professionals propose hospice as an alternative for individuals
with stage D heart failure while contemplating cutting-edge treatments. The Medicare
Hospice Benefit provides emotional, physical, spiritual, medical, and social services to
patients with a life expectancy of less than or equal to six months and who decide to
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forego life-extending treatments. Previous studies have reported that, in advanced cancer
patients, hospice increased chances of survival, decreased healthcare expenses, reduced
patients’ physical and psychological warning signs, and improved family satisfaction and
caregiver well-being. Even though symptomatic heart failure has a poorer prognosis than
the majority of cancers, advanced heart failure patients register in hospice at lesser rates
than individuals with cancer. Substantial declines have been reported in ICU admissions
and ER visits following hospice registration (Yim et al., 2017). Individuals with heart
failure might not be given the complete advantage of hospice benefits when registration
times are less than or equal to one week, and this has been previously linked to reduced
quality for end-of-life care for patients and families (Yim et al, 2017). A study conducted
by the US Department of Health and Human Services reported that the benefits of hospice
treatment are not apparent until at least 30 days after admission (Yim et al., 2017).
Scheduling an appointment for referral to hospice is difficult due to the erratic clinical
progression of heart failure. Research indicates that the number of ICU admissions,
hospital admissions, and ER visits are all reduced after enrollment into hospice, similar to
other clinical populations (Yim et al., 2017).
Mortality Rates of Heart Failure Patients 65 Years and Over
Heart failure has a massive cost and a bleak diagnosis, with a typical 1-year
mortality of 33%-35% (Azad & Lemay, 2014). Frailty is linked to mortality and
hospitalizations and negatively impacts heart failure management in older adults by
effecting their self-care and reducing their ability to register for clinical trials. Frailty is
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associated with standard heart failure symptoms such as decreased exertional capacity and
fatigue and all-cause hospitalizations and mortality, even in advanced heart failure patients
who obtain ventricular-assist tools (Madan et al., 2016).
In an examination of 6.5 million heart failure patients in the United States, the inhospital unadjusted mortality rate dropped from about 8.5% during 1993 to almost 4.3%
during 2006 (Cowie et al., 2014). Moreover, the 30-day mortality rate dropped from 12.8
to 10.7% for the identical amount of time. Additional Medicare examinations have also
reported a reduction in hospital mortality rates, from about 5.1% during 2001 to
approximately 4.2% during 2005 (Cowie et al, 2014). However, one-year all-cause and
480-day mortality rates stayed unchanging at about 37% and 26%, respectively. An
examination of statistics from 55 million Medicare beneficiaries also reported a decrease
in the one-year mortality rate from 31.7% during 1999 to 29.6% during 2008 (Cowie et al.,
2014). Despite continuing improvements in care for heart failure, the survival odds
following an incident of acute heart failure continue to be low and five-year mortality rates
are about 70%. In a community-based study within the United States, the five-year
mortality rate for individuals recently diagnosed with heart failure increased from 57% in
1979 to 48% in 1984 (Cowie et al., 2014). In another community-wide study examining
severe heart failure, two-year and five-year post-discharge mortality rates among
hospitalized individuals improved from 1995 to 2004 (Cowie et al., 2014).
A national heart failure audit conducted in the UK from April 2010 to March 2011
revealed that inpatient mortality rates were higher among individuals hospitalized in
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cardiology departments compared to those in internal medicine and other departments
(Driscoll et al., 2016). Lower heart failure mortality rates have also been reported among
individuals that obtained follow-up care at cardiology clinics compared to non-cardiology
clinics (Driscoll et al., 2016). Similarly, lower mortality rates have also been observed
among heart failure patients that obtained follow-up care with a nurse having heart failure
expertise compared to follow-up care with a nurse lacking heart failure expertise (Driscoll
et al., 2016). The utilization of specialist heart failure nurses within heart failure programs
also enhanced patient results. Several meta-analyses of heart failure programs have
revealed that systems that have nurses with heart failure expertise and training in critical
care or cardiovascular care have better patient outcomes than systems that do not have
nurses with this type of expertise (Driscoll et al., 2016).
Hospital Readmission Rates of Heart Failure Patients 65 Years and Over
In 2005, the 7-day hospital readmission rate for heart failure Medicare beneficiaries
was 6.2%, 15-day readmission rates were 12.5%, and 30-day readmission rate was 17.6%.
Many of these 7-day, 15-day, and 30-day readmissions were considered avoidable
(Chamberlain et al., 2018). The ACA established the Hospital Readmissions Reduction
Program (HRRP) in October 2012, which mandated that the Centers of Medicare and
Medicaid Services (CMS) monetarily penalize institutions with high readmission rates by
decreasing hospital reimbursements. The Healthcare Cost and Utilization Project (HCUP)
reported a drop in all-cause 30-day rates of readmission among adults with heart failure
from 25.1% in 2009 to 23.5% in 2013, saving about $200 million (Chamberlain et al.,
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2018). The Medicare Payment Advisory Commission (MedPAC) projected that 12% of
readmissions to the hospital are possibly preventable. Avoiding as little as 10% of these
excess readmissions can allow Medicare to save $1 billion (McIlvennan et al., 2015).
Moreover, in 2016, MedPAC reported a drop in avoidable readmission rates from
19.5% in 2010 to 17.0% in 2014 among individuals with heart failure (Chamberlain et al.,
2018). By the beginning of 2014, two thirds of hospitals were already penalized for excess
readmission rates (Chamberlain et al., 2018). As a result, health centers and hospitals
began to prioritize detecting heart failure patients with the highest risk of readmission and
authorizing preventative intervention and early risk stratification. Medicare beneficiaries
have higher readmission rates compared to individuals with private insurance and
Medicaid (Chamberlain et al., 2018). Medicare recipients with heart failure have the
highest readmission rates, with research indicating that 18% of six-month all-cause
readmission rates were due to heart failure. In a study examining administrative discharge
figures on 41,776 individuals admitted to 236 hospitals in New York State, there was a
declining trend in heart failure readmission rates from the lowermost income quartile to
the uppermost (Chamberlain et al., 2018). The authors also discovered that salary was a
statistically significant predictor of readmission, with lower salaries associated with a
greater likelihood of readmission (Chamberlain et al., 2018).
Readmission rates are highest in the elderly within three to six months after
discharge and fluctuate between 27% - 47% (Azad & Lemay, 2014). Cognitive function is
one factor that may contribute to readmission in elderly individuals in several ways. First,
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the requirements of self-care for ideal heart failure management are extensive; general
instructions for discharge consist of symptom monitoring, daily weighing, compliance
with a low sodium diet, multidrug treatment, and fluid restriction. Cognitive impairment
could affect any of these essential responsibilities. For example, dosages of diuretics could
be misunderstood, or symptoms, such as weight gain, might be overlooked until they
become critical. These factors could explain why heart failure patients have one of the
highest early readmission rates following discharge (Azad & Lemay, 2014).
Even though overall rates for heart failure hospitalization among Medicare
recipients decreased between 1998 and 2008, unexpected readmissions continue to be a
common occurrence, with approximately one in four patients readmitted within 30 days of
discharge. In a study analyzing Medicare heart failure claims from 2009-2012, only 1.4%
of hospitals had attained a 20% decrease in 30-day readmission rates by December of 2012
(Bergethon et al., 2016). This percentage was similar to those from reports based on data
from the Hospital Compare database, in which only 2.6% of hospital sites attained a 20%
relative decrease from the periods of July 2006 to June 2009 vs. July 2009 to June 2012.
These outcomes for heart failure patients are reliable, with current information indicating
that reductions in overall readmission rates for fee-for-service Medicare recipients have
been minimal, despite financial incentives and increased efforts among health systems
(Bergethon et al., 2016).
A common reason for readmissions is cardiac disease, with the reappearance of
heart failure making up approximately 30% of all cases (Cowie et al., 2014). In the United
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States, 30-day readmission rates were around 20%-25% (Cowie et al., 2014). An
examination of Veterans Affairs (VA) healthcare data from 2002 to 2006 indicated a rise
in 30-day rehospitalization for heart failure and better survival over this interval (Cowie et
al., 2014). This study reported that appropriate post-discharge appointments utilized
through the VA and prompt readmittance to the hospital for heart failure were linked to
better patient outcomes (Cowie et al., 2014).
Quite a few United States national quality improvement programs have been
created in an attempt to decrease 30-day hospital readmissions. One such initiative is
called Get with the Guidelines (GWTG). GWTG was created through the American Heart
Association to promote the application of evidence-based clinical practice procedures to
enhance patient results post-discharge. Mortality and readmission rates were substantially
lowered in hospitals participating in the GWTG initiative (Driscoll et al., 2016).
Despite substantial therapeutic developments, individuals with heart failure need
regular hospital admissions for heart conditions such as congestion, arrhythmia,
uncontrolled hypertension, hypervolemia, and ischemia, as well as non-cardiovascular
comorbidities. Results from observational studies suggest that the bulk of individuals
identified with heart failure will be admitted to the hospital at least one time, and more
than half will be admitted to the hospital three or more times within four to five years of
diagnosis. Nearly 25% of individuals with heart failure are admitted to the hospital again
within 30 days (Kilgore, Patel, Kielhorn, Maya, & Sharma, 2017).
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Considerable attention has been paid to the association between mortality and
readmission rates. A study examining CMS Hospital Compare data regarding heart failure
statistics found a statistically significant inverse correlation between 30-day mortality rates
and 30-day readmission rates (McIlvennan et al., 2015). A subsequent evaluation of
hospital-level risk-standardized mortality and readmission rates reported a small inverse
relationship between readmission coupled with mortality rates for heart failure
(McIlvennan et al., 2015). There are numerous reasons as to why heart failure mortality
and readmission rates are inversely related. One possibility is that some institutions have a
low level of admittance along with readmission; such institutions might admit patients
with less severe cases of heart failure, therefore resulting in higher rates of readmission
and lower rates of mortality. An alternate justification is that hospitals with high mortality
rates have fewer individuals for readmitting; a patient known to be high-risk who perishes
within the institution is not able to be readmitted. Similarly, a patient who perishes at his
or her residence abruptly following initial release from the hospital cannot be admitted
again (McIlvennan et al., 2015).
Financial Burden of Heart Failure on Patients
Heart failure is the principal reason for hospitalization for individuals over 65 years
and represents a substantial economic and clinical burden. Outpatient and inpatient
expenses associated with heart failure management make it one of the most expensive
health care issues (Azad & Lemay, 2014). Heart failure is also one of the most frequent
and costly medical illnesses within Medicare. Following heart failure diagnosis, 83% of
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individuals are admitted to the hospital at least one time, and 43% a minimum of 4 times
(Kumbhani et al., 2018). Heart failure is a considerable burden to the United States health
care system, costing citizens about $30.7 billion yearly (Bergethon et al., 2016). The
syndrome impacts approximately 6.5 million adults and is expected to rise to more than 8
million incidents by the year 2030. It is estimated that the percentage of the population 65
years and older with heart failure will rise from 6% in 2012 to approximately 71% by
2030. Overall direct medical expenses for heart failure were assessed to be about $21
billion in 2012 and expected to rise to roughly $53 billion in the year 2030 along with the
percentage of the populace 65 years and older climbing from 81% to 88%, creating
significant monetary liability for Medicare. Most of the expenses among the populace
(80%) with heart failure are linked with hospital admissions, and approximately 15% of
the hospital admission expenses are for the care of deteriorating heart failure (Fitch et al.,
2018). In an examination of 1.1 million Medicare beneficiaries during 2010, expenses for
heart failure hospitalization resulted in approximately $91.9 million, making up for 3.1%
of the overall Medicare expenditure (Cowie et al., 2014).
Hospital admissions are especially resource-intensive; costs for inpatient care are
approximately $83,980 throughout the lifespan of each person with heart failure. One
research study reported that nearly 80% of the overall lifetime expenses associated with
heart failure are accrued for the duration of hospital stays (Kilgore et al., 2017). The
overall mean per-patient amount of one heart failure-associated hospitalization was
estimated at $14,631, with CMS covering $13,073, and $1,558 taken care of by other
payers. Individuals with heart failure are likely to accumulate at least $34,000 in
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hospitalization expenditures each year. This outcome is considerably greater than that
observed in a 2012 analysis in which the overall medical expenses among Medicare
recipients during the one-year period following initial hospital admission for heart failure
were $22,124 (Kilgore et al., 2017).
The yearly fee-for-service treatment cost for deteriorating heart failure is $12.8
billion, which is 3.3% of the yearly overall Medicare fee-for-service populace spending
(Fitch et al., 2018). Patients with heart failure have three times the average per-memberper-month costs compared to the total Medicare fee-for-service populace ($3,482 permember-per-month for patients with heart failure compared to $1,072 per-member-permonth for Medicare fee-for-service populace), and four times the average per member per
month costs when compared to the non-heart failure Medicare fee-for-service populace
($3,482 per-member-per-month for patients with heart failure compared to $791 permember-per-month for patients without heart failure) (Fitch et al., 2016).
Heart failure represents a massive economic load for healthcare systems within
developed countries. For example, the United States and Europe paid one to two percent of
their yearly healthcare budget on heart failure (Lesyuk et al., 2018). The global economic
problem of heart failure is estimated at $108 billion each year, with $43 billion assigned to
indirect costs and $65 billion assigned to direct costs. The United States is the main
contributor to international heart failure expenses and is accountable for 20.4% of overall
global heart failure spending (Lesyuk et al., 2018). Hospitalization expenses are the
greatest contributor to healthcare fees, while costs for prescription drugs are the second
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greatest contributor. Among hospitalization expenses, room and board were the most
costly, after procedures, laboratory testing, and imaging. Dialysis had the highest
procedural costs, but this procedure was only required for a small number of patients.
Newly diagnosed heart failure patients had considerable healthcare costs (Lesyuk et al.,
2018). Compared to the control group without heart failure, individuals with heart failure
had four times greater overall healthcare expenses. The most frequent causes of rising
expenses for patients with heart failure were diabetes mellitus, kidney dysfunction, a
higher NYHA (New York Heart Association) stage, and comorbidity. Heart failure
comorbidities contribute to three-fourths of all readmissions in patients with heart failure.
Dunlay et al. (2011) found that diabetes mellitus increased lifetime expenses of heart
failure patients by 25%. Bogner et al. (2010) further reported that diabetes mellitus causes
prolonged stays in the hospital and worsens the prognosis. Studies indicate that the
financial burden of heart failure relies on the NYHA stage, and that costs increase with
more advanced stages. Two studies examined healthcare expenses among heart failure
patients during the initial year of heart failure diagnosis compared to the year prior to
diagnosis and found that there was a 318% increase in healthcare expenses during the
initial year following heart failure diagnosis compared to the prior year (Lesyuk et al.,
2018). The research further revealed that expenses were high during the first year
following heart failure diagnosis, then dropped and attained a steady, relatively low level,
and then increased again at the end of the patient’s life (Lesyuk et al., 2018).
Heart failure-associated medical expenditure rose 4.8-fold (a rise of $5,917) from
the sixth month to the first month prior to death, with a 5.3-fold surge (an increase of
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$5,690) reported for inpatient expenses. Within this analysis, average all-cause inpatient
and medical expenses throughout the six months prior to death were $25,600 and $37,186,
respectively, for Medicare Advantage with Part D (MAPD) enrollees (Obi et al., 2016).
These results are similar to hospitalization ($20,309) and medical costs ($36,216) through
the utilization of 2007 Medicare statistics. The study also reported that expenses related to
inpatient hospitalizations were the primary expenses throughout the last six months prior
to death (Obi et al., 2016). This finding is similar to a recent report of higher inpatient
hospitalization resource utilization during the final two months of life (Obi et al., 2016).
Additional studies have reported that throughout the last six months, just over one-quarter
of all-cause inpatient expenses for commercial and MAPD beneficiaries (28.7% and
27.8%, respectively) were not attributable to heart failure-associated inpatient expenses
(Obi et al., 2016). This indicates that a considerable percentage of these hospitalizations
may be linked to comorbid diseases. Earlier findings have reported a connection between
higher hospitalization risk and comorbidity in patients with heart failure. Even though
heart failure-related care makes up a considerable share of all-cause expenses, comorbid
illnesses might also be a significant factor (Obi et al., 2016).
Impact of Patient Age on Heart Failure Patients
The incidence and prevalence of heart failure increase with patient age. Heart
failure is a significant cardiac condition that increases 10-fold from age 60 to age 80 (Azad
& Lemay, 2014). Due to the aging population in the US and improved life expectancy, the
frequency of heart failure is likely to grow to roughly 46% by 2030, resulting in over eight
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million heart failure adults (Zhao et al., 2019). Consequently, for individuals aged 45-55
years, the occurrence of heart failure is less than 1%, but frequency rises to about 10% in
patients over the age of 80. Mortality in older heart failure patients has increased
significantly; statistics indicate that the average life expectancy in elderly heart failure
patients is about 2.5 years, with approximately 25% perishing within the initial year
(Berliner & Bauersachs, 2018). The lifetime risk of developing heart failure is 1 in 5, and
its occurrence grows with age; there is an increase from 1.4% - 1.9% among patients who
are middle aged to 12.8% - 14.7% among patients who are octogenarians. Elderly
individuals with heart failure are frequently female, have decreased cardiac illnesses and
related risk issues, but possess increased rates of non-cardiac co-morbidities (Azad &
Lemay, 2014). Over 50% of patients with heart failure who are greater than or equal to 60
years old describe some amount of mobility restriction and countless struggles with dayto-day living, such as dressing, bathing, and eating. Functional disability and mobility are
linked with cognitive weakening and comorbidity burden. This link is most likely
bidirectional. A noteworthy extra contributor is frailty - a multi-systemic, aging-related
condition that incorporates weakness, fatigue, and reduced tolerance to physiological
stressors (Butrous & Hummel, 2016).
Early discovery of heart failure by doctors is hindered by a lack of specific warning
signs, the existence of comorbidities, and limited admissions to echocardiography (Riet et
al., 2014). Attempting to detect heart failure without echocardiography can lead to a
significant number of false positives and false negatives. One of the main non-specific
symptoms of heart failure is shortness of breath from exertion (dyspnea). Even though
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dyspnea is frequent in older individuals, assessment of this warning sign is difficult
because it has subjective qualities, and several circumstances are proven to trigger it, as
well as pulmonary illnesses. Since unrecognized heart failure is widespread in the elderly
arriving at primary care facilities with dyspnea, careful assessment is important in these
patients (Riet et al., 2014). Even though elderly patients are not often included in clinical
experiments, all heart failure treatments, from devices to drugs, are, nevertheless, used
among the elderly. The best method of treatment must be decided based on each patient’s
unique condition and must consider factors such as such as frailty, economic background,
comorbidities, social, and quality of life (Guerra et al., 2017).
Chronic Care Model Alignment with Heart Failure
The Chronic Care Model (CCM) is a well-established model meant to change
health care by concentrating on improving patient care using strategies at the organization,
patient, practice, and community levels. Though broad implementation of this model has
occurred globally for managing chronic illness, few studies have examined its success in
enhancing outcomes in patients with heart failure (Ballo et al., 2018). A metanalysis
established that CCM is beneficial for heart failure patient care, but has considerable
variations in success (Drewes et al., 2012).
CCM was independently linked to a 35% decreased likelihood of hospitalization
for heart failure (Ballo et al., 2018). After an initial admission for heart failure, no
variations were detected between the two categories (the control group and CCM group) in
danger of additional hospitalizations for heart failure. There was no substantial difference
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between the control and CCM group in regard to 30-day heart failure readmission rates
after an initial hospitalization. When urgent and planned hospitalizations for heart failure
were considered separately, CCM was linked to a pointedly greater rate of hospitalizations.
Through multivariate analysis, it was established that CCM was linked to an 18% lower
risk of mortality. Remarkably, even after being admitted, heart failure patients in the CCM
group indicated a 16% lower risk of death compared to controls. Results indicated that
CCM patients had a lower risk of death, but an increased risk of being admitted to the
hospital for heart failure than a matched control populace. Previous studies, typically
conducted in hospitals, have reported that implementation of CCM for heart failure
patients with continuing cardiac issues could be beneficial, but there is variability in its
success (Ballo et al., 2018).
A multidisciplinary approach, founded upon standards of CCM, is the best method
for guaranteeing the best social and clinical results for heart failure patients (Lorenzini et
al., 2016). The best environment to build coordination of heart failure care with staff is
through CCM, to convert information among actual care practices and evidence-based
chronic disease care. CCM proposes that six interconnected foundations are crucial for
top-quality care of chronic disease, including: clinical data technology, restructuring
delivery structures, self-management support, system-wide decision support, connections
to resources within the community, and hospital organization. Primary care is a vital part
of the initial detection of heart failure, management of end-of-life care along with comorbidities, and self-care awareness. However, a thorough systematic review of twentytwo studies reported obstacles to executing CCM within primary care settings (Lorenzini
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et al., 2016). Evaluating organizational capability and requirements and obtaining a clearer
understanding of organizational perspective and healthcare providers is critical during the
application of the CCM. In chronic disease, patient-centered care has a positive impact
between providers and patients concerning strategies for treatment, patient satisfaction,
patient health outcomes, and respecting patients’ preferred amount of participation in
healthcare choices. Education for patients is focused on helping patients understand their
illness and make appropriate choices concerning their treatment and wellbeing rather than
simply providing assessments related to the illness. Counseling remains the best method
for steering, aiding, and improving empowerment and self-management among individuals
and their caregivers by providing education and self-care skills and allowing patients to
make their own treatment decisions. Patients’ ability to manage persistent illnesses is vital
to enhancing health results, and a patient-centered methodology regarding heart failure
supervision is generally advised. Counseling for heart failure should be centered on
straightforward activities that caregivers and patients can implement. Incorporated patientcentered care systems have conclusively shown a substantial decrease in hospital
admissions, mortality, and readmissions, including emergency department admissions
(Lorenzini et al., 2016).
Doctors and nurses must supervise patients with chronic illnesses through periodic
checkups that evaluate patients’ active participation and early discovery of deterioration of
the illness along with its sources. After each meeting, healthcare specialists must assess
patients’ comprehension of what has been discussed. For advanced heart failure patients,
healthcare professionals should remain adaptable, and the consultation must offer clear-cut
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suggestions to family members and patients regarding when to consult a doctor and
indications of destabilization, which necessitate professional guidance (Lorenzini et al.,
2016).
Definitions
Centers for Medicare and Medicaid (CMS): A segment of the Department of
Health and Human Services (“About CMS,” 2018).
Excess Readmissions: Calculating an institution’s rates of readmission, adjusting
for sex, co-existing illnesses, and age, which are contrasted to nationwide rate norms and
resulting in above average rates (McIlvennan et al., 2015).
Geriatric Heart Failure Patient: An elderly person receiving special care for heart
failure at the hospital. They constitute about 80% of individuals who suffer from heart
failure (Díez-Villanueva & Alfonso, 2016).
Length of Stay (LOS): Number of days admitted in the hospital for a single episode.
LOS is a significant marker of the utilization of medical services to evaluate the
competence of hospital management, functional evaluation, and quality of care for
patients. Reduced LOS has been linked to a lower risk of infection and side effects of
medicine, and with enhancements in treatment results and reduced rates of mortality (Baek
et al., 2018).
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Medicare Part C Program: The program offers all of Part A (hospital insurance),
Part B (medical insurance) coverage, and most programs include Part D (prescription drug
coverage) (“What is Medicare Part C?”, 2014).
Medicare Utilization: Medicare is a health insurance program conducted by the
federal government for individuals who are over the age of 65, those diagnosed with EndStage Renal Disease, and younger people with disabilities (“What is Medicare?”, 2018).
Mortality Rates for Heart Failure Patients: Measure of the frequency of
occurrence of death in the heart failure population during a specified interval (Bytyçi &
Bajraktari, 2015).
Patients Diagnosed with Heart Failure: Patients presenting to the hospital with
International Classification for Disease (ICD)-9 codes of 428.0 through 428.9
(Chamberlain et al., 2018).
Readmission Rates for Heart Failure Patients: Admittance to an institution in the
span of 30 days from discharge for heart failure (“Readmissions-Reduction-Program,”
2019).
Assumptions
One assumption in this study is that the Medicare utilization information, mortality
rates, and readmission rates for heart failure patients (provided through
data.medicare.gov/data/hospital-compare and cms.gov/Research-Statistics-Data-andSystems/Statistics-Trends-and-Reports/Chronic-Conditions/CC_Main) is accurate and
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provides nationally representative data. This assumption is necessary in order to examine
how utilization of Medicare impacts mortality and readmission rates of heart failure
patients 65 years and over.
Scope and Delimitations
Factors examined in this study include the link between Medicare and heart failure
outcomes, mortality rates of heart failure patients 65 years and over, readmission rates of
heart failure patients 65 years and over, the financial burden of heart failure on patients,
and the impact of patient age on heart failure patients improve the understanding of how
utilization of Medicare impacts mortality and readmission rates of heart failure patients 65
years and over. The study population is Medicare patients 65 years and over seen in
hospitals within the United States and diagnosed with heart failure from 2015 to 2017.
The generalizability of the study is limited to patients admitted to the hospital for
heart failure, diagnosed with heart failure, possessed Medicare, aged 65 and over, and
other factors that may influence mortality and readmission rates for heart failure Medicare
beneficiaries. Studies have previously found that hospitals vary in readmission or mortality
rates according to culture, patient volume, organizational structure, academic status,
financial structure, and information technology (Horwitz et al., 2012).
Significance, Summary, and Conclusions
By examining if there is a relationship between Medicare-covered services for care,
mortality rates, and readmission rates for beneficiaries 65 years and over with heart failure,
this study contributes to the field of health care administration by improving our
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understanding of the relationship between these factors in heart failure patients 65 years
and over. Readmission rates are elevated in the elderly within three to six months after
discharge, fluctuating between 27% - 47% (Azad & Lemay, 2014). Understanding these
factors and the impact they have upon heart failure patients 65 years and over is significant
to health care administrators, as the CMS is imposing fines against hospitals for excess
readmissions (Chamberlain et al., 2018). These fines are significant to health care
administrators, as the penalties can rise to 3% of the hospital’s overall Medicare payments
and applied for one year, possibly affecting the financial strength of the institution
(McIlvennan et al., 2015). Preserving the viability and financial stability of institutions

supports admittance to care for patients by preventing hospital closings resulting from
reduced profit margins due to enforced fines by the CMS (Fitch et al., 2018).
Specific themes in the literature concern Medicare, mortality, and heart failure
hospitalizations. Even though in-hospital mortality has reduced throughout the past ten
years among Medicare beneficiaries, 30-day mortality has reduced at a more gradual rate
as a result of an increased amount of deaths that transpire the following discharge from
heart failure hospitalization (Chen et al., 2013). Policymakers and researchers recognize
the 30-day hospital readmission rate for heart failure as an unnecessary and avoidable
expense (Wadhera et al., 2018).
There is minimal literature regarding patients 65 years and over and heart failure
clinical experiments. Elderly patients are not often represented in clinical experiments
(Guerra et al., 2017). Previous heart failure clinical trials, upon which present therapy
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standards are based, mainly involve younger patients. Consequently, a gap remains
regarding patients registered in clinical trials and those handled in everyday clinical
practice. There is also minimal literature examining the Chronic Care Model’s success in
enhancing results in heart failure patients, even though this model has been broadly
implemented globally for managing patients with chronic illnesses (Ballo et al., 2018).
This study, therefore, fills the gaps existing in the current literature, offering an expansion
of understanding and practical application in the field of health care administration.

Section 2: Research Design and Data Collection
In the preceding section, current literature was reviewed based on critical variables,
including: the link between Medicare and heart failure outcomes, mortality rates of heart
failure patients 65 years and over, readmission rates of heart failure patients 65 years and
over, financial burden of heart failure on patients, impact of patient age on heart failure
patients, and Chronic Care Model alignment with heart failure. This study involves
Hospital Compare data from CMS for Medicare patients 65 years and over who were seen
in hospitals within the United States and diagnosed with heart failure from 2015 to 2017.
The purpose of the study is to quantitatively investigate the factors influencing mortality
and readmission rates among heart failure Medicare patients 65 years and over. In this
section, specifics will be provided regarding the research design, methodology, and
analytical tools used in this study.
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Research Design and Rationale
The dependent variables in this study are mortality and readmission rates among
heart failure Medicare patients 65 years and over. The independent variable is the
utilization of Medicare. This study will use a quantitative, nonexperimental design
utilizing retrospective archival Hospital Compare data from the CMS website from 2015 to
2017 to conduct a correlational analysis followed by multiple regression. This research
design is consistent with previous studies examining mortality and hospital readmission
rates for elderly heart failure patients. Pacho et al. (2018) examined mortality rates and 30day readmission rates in frail, elderly heart failure patients. The authors utilized
correlational analysis and multiple regression analysis for evaluating outcomes.
Chamberlain et al. (2018) also studied 30- day readmission rates for heart failure patients
using multiple regression analysis. Dharmarajan et al. (2017) analyzed changing hospital
readmission rates and mortality rates for heart failure patients while also applying
correlational analysis and logistic regression analysis.
Methodology
Study Population
The target population for this study was Medicare heart failure patients 65 years
and over. The CMS Hospital Compare data for 2015 to 2017 regarding mortality and
readmission rates for Medicare heart failure patients 65 years and over, will be utilized for
evaluation.
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Sampling and Sampling Procedures
Hospital Compare is an element of the Centers for Medicare & Medicaid Services
Hospital Quality Initiative. It was formed via the efforts of the Hospital Quality Alliance
(HQA) and Medicare. This initiative utilizes different tools to aid hospitals in improving
the quality of care they provide. The goal is to support the improvement of hospitals’
quality of care via easily comprehendible data on quality statistics and hospital
performance from the perspective of patients (“About Hospital Compare Data,” 2020).
The sampling strategy is relevant. Every Medicare recipient’s status and age are
concluded based on a value at the end of the year (“Data Sources and Methodology,”
2020). A Medicare recipient is deemed to possess a chronic illness if the administrative
data within CMS has a claim showing that the recipient accepted treatment or service for a
specific condition (“Chronic Conditions Data Warehouse,” 2020).
Hospital-specific death rates and readmissions were assessed using Medicare
claims information and eligibility records from 2015 to 2017. The mortality and
readmission measures incorporate hospitalizations for Medicare recipients 65 years and
over who were registered in Original Medicare one year prior to their hospital admittance.
When concerning readmission rates, measures involved Medicare recipients 65 and over
registered in Original Medicare for 30 days following their initial admittance
(“Readmission and Death Measures,” 2020). The information is accessible from the CMS
Chronic Condition Data Warehouse (CCW), www.ccwdata.org. For all the chronic
condition reports, the Medicare recipient populace is limited for recipients of fee-for-
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service. Medicare recipients with any Medicare Advantage registration throughout the year
were excluded since claims data are not available for these recipients. Also, recipients who
registered at any point within the year in just Part A or only Part B were excluded, due to
the fact that their spending and utilization was not directly comparable to recipients
registered in both Part A and Part B. Recipients who perish within the year were included
up to their death date if they met the other inclusion factors (“Chronic Conditions,” 2020).
The CCW has restricted, optional data available to allow users to create estimated
cohort sizes using chronic condition, diagnosis/procedure parameters, demographic, and
enrollment factors. The information includes only Dual Eligible and Medicare recipients
(“Chronic Conditions Data Warehouse,” 2020). However, accessibility for the secondary
data for this study uses the CCW publicly accessible information. Since the information is
accessible publicly, there are no required permissions to obtain access to the records.
Power Analysis
Sample size and power analysis assumed an overall medium effect size association
between predictor and outcome variables. Based on previous literature, a medium-sized
association is a reasonable assumption (Amarasingham et al., 2010). The alpha (0.05) and
power (0.80) thresholds are set by convention (Brydges, 2019). Based on the results of the
power analysis, the required sample size for the linear multiple regression analysis is 55
(Cohen’s f₂ = 0.15, alpha = 0.05, power = 0.80, and a single predictor), as shown in Table
1. Sample size and power estimation was conducted through utilization of G*Power
3.1.9.2.
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Table 1
Linear Multiple Regression Power Analysis Utilizing G*Power
Input:

Output:

Tail(s)

Two

Effect size f₂

0.1494253

α err prob

0.05

Power (1-β err prob)

0.80

Number of predictors

1

Total sample size

55

Actual power

0.8035892

Operationalization of Variables
One independent and two dependent variables will be investigated in this study.
Medicare utilization is the independent variable, while mortality rates among patients 65
years and over is one dependent variable, and readmission rates is another dependent
variable.
The independent variable, Medicare utilization, is measured when a Medicare
beneficiary 65 years or over was admitted to the hospital for heart failure. The dependent
variable, mortality rates, focused on whether Medicare heart failure patients 65 years and
over died within a span of 30 days following their admittance to the hospital. The other
dependent variable, readmission rates, focused on whether Medicare heart failure patients
65 years and above were readmitted to the hospital within 30 days. Mortality and
readmission rates will be computed using claims records and Medicare enrollment.
Mortality and readmission rates are risk-adjusted. The 30-day time frame is utilized since
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this is the amount of time when deaths are most likely to be linked to the treatment patients
obtained within the hospital (“Death Rates,” 2020).
Data Analysis Plan
I utilized the Statistical Package for the Social Sciences (SPSS), Version 25 for
analysis of the data from 2015 to 2017 offered through CMS. Readmission rates and
mortality are risk-adjusted. The computations considered how ill patients were when they
were admitted for initial hospitalization. Risk-adjusted rates allow for comparisons across
hospitals to be fair and significant by adjusting for differences in the patient mix and
allowing individuals to assess actual fluctuations in performance (“Hospital Mortality and
Readmission Data,” 2018). Data included within the years 2015 to 2017 that did not apply
to the research and related variables, were not incorporated in the statistical assessment.
Research Questions and Hypotheses
RQ1: Is there a relationship between the Medicare-covered services for care and
mortality rates of patients 65 years and over with heart failure?
H1: There is no relationship between Medicare-covered services for care
and mortality of patients 65 years and over with heart failure.
H1: There is a relationship between Medicare-covered services for care and
mortality of patients 65 years and over with heart failure.
RQ2: Is there a relationship between Medicare-covered services for care and
readmission rates of patients 65 years and over with heart failure?
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H2: There is no relationship between the Medicare-covered services for
care and readmission rates of patients 65 years and over with heart failure.
H2: There is a relationship between Medicare-covered services for care and
readmission rates of patients 65 years and over with heart failure.

Detailed Analysis Plan
Correlational analysis followed by multiple regression analysis was used to test the
hypotheses, as the goal of assessment is to analyze the links between mortality and
readmission with the utilization of Medicare. Additionally, multiple regression analysis
offers the ability to observe the impact of independent variables with dependent variables
while adjusting for the effect of one variable while assessing the impact of the other
(Schaik et al., 2019). Study outcomes will be centered on the standard threshold for
multiple regression testing using an alpha cutoff of 0.05.
Validity
External Validity
The study’s data consists of secondary data collected to produce accurate
nationwide results. Approximately 30% of Medicare recipients are registered in a
Medicare Part C program via a private insurer, and this proportion has risen gradually
since 1999. Information on recipients protected by Medicare Part C programs are not
incorporated in the Standard Analytic Files (SAFs) supplied to scholars utilizing CMS.
Medicare Part C claims are accessible in some US commercial claims databanks, but
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merging these claims with CMS Fee-For-Service files might not be viable (Mues et al.,
2017). Thus, it is consequently challenging to perform studies on the whole population of
Medicare.
Internal Validity
Data on patient characteristics such as exercise, diet, laboratory test outcomes,
outcomes of diagnostic exams, and additional disease severity markers were not available.
As with most other claims databanks, illnesses are usually specified in Medicare records
via the existence of a diagnostic code. This method might be susceptible to
misclassification depending on the type of ailment under examination, and the capability
to differentiate severe from mild illness might be limited unless other claims for services
such as treatment or procedure are incorporated into the description. Since several of these
factors are prognostic signs that could impact decisions for treatment, comparative
effectiveness utilizing these data might be exposed to residual inaccuracy (Mues et al.,
2017).
Construct Validity
Within Medicare, problems can arise by the extension of the amount of ICD-9/10
diagnosis and procedure code fields on a claim from 9 and 6 to 25 and 25, respectively.
This development occurred in 2010, but did not visibly impact the resultant information in
the SAFs until January 2011. This development in the number of accessible fields could
end in a synthetic rise in estimations of illness burden, primarily if more sensitive
classifications of illnesses are used (Mues et al., 2017).
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Ethical Procedures
Data from CMS from 2015 to 2017 is publicly available secondary data that deidentifies patients. Since the information de-identifies patients, no threats were possible for
the discovery of classified health knowledge in the data that will be utilized for the study.
The data will be downloaded, saved on a private laptop, and will be removed once the
research is completed. In this way, the security of the data will be preserved. For ethical
reasons, the Institutional Review Board supervised the data assessment and study
decisions.
Summary
Section 2 described utilization of secondary data from CMS to perform quantitative
analysis through correlational and multiple regression analysis. The study aimed to
determine if there is a relationship between Medicare utilization and mortality and
readmission rates. Additionally, Section 2 contains the proposed methodology for the
study, and Section 3 will offer the statistical results linked to the research questions and
related hypotheses.

Section 3: Presentation of the Results and Findings
Introduction
The purpose of this quantitative study was to determine if there is a relationship
between Medicare-covered services for care, mortality rates, and readmission rates for
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beneficiaries 65 years and over with heart failure. The data from the CMS Chronic
Conditions Data Warehouse for the years 2015, 2016, and 2017 contain the independent
and dependent variables utilized to analyze mortality and readmission rates of Medicare
heart failure beneficiaries 65 years and over. Mortality rates among patients 65 years and
over is a dependent variable, readmission rates are another dependent variable, and
utilization of Medicare is the independent variable. Utilizing these independent and
dependent variables, the research questions and associated hypotheses are as follows.
RQ1: Is there a relationship between the Medicare-covered services for care and
mortality of patients 65 years and over with heart failure?
H1: There is not a relationship between the Medicare-covered services for
care and mortality of patients 65 years and over with heart failure.
H1: There is a relationship between the Medicare-covered services for care
and mortality of patients 65 years and over with heart failure.
RQ2: Is there a relationship between the Medicare-covered services for care and
readmission rates of patients 65 years and over with heart failure?
H2: There is not a relationship between the Medicare-covered services for
care and readmission rates of patients 65 years and over with heart failure.
H2: There is a relationship between the Medicare-covered services for care
and readmission rates of patients 65 years and over with heart failure.
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Section 3 includes results of the statistical analyses (correlation and multiple
regression) of data utilized from the 2015, 2016, and 2017 found on the CMS website.
Brief descriptions are provided of the survey time frame for data collection, descriptive
characteristics of the sample, representativeness of the sample and conclusion with a
summary of the results.
Data Collection of Secondary Data
Time Frame
For this study, archival data was downloaded from the CMS website for the years
2015, 2016, and 2017. The data selected for the study were for mortality and readmission
rates for heart failure Medicare beneficiaries 65 years and over. The CMS Chronic
Conditions Data Warehouse contains variables for sixty-six conditions. A Medicare
recipient is deemed to possess a chronic illness if the administrative data within CMS have
a claim showing that the recipient accepted treatment or service for a specific condition.
These variables are created to aid scholars in the detection of cohorts of Medicare
recipients who have specific illnesses. The condition variables are constructed from
algorithms that comb the administrative claims data within CMS for specific MS-DRG
codes, procedure codes, or diagnosis codes (“Chronic Conditions Data Warehouse,” 2020).
The data are compiled from all 50 U.S. states, the District of Columbia, Puerto Rico, and
the U.S. Virgin Islands.
The G*Power analysis required a sample size of 55 (power = 0.80 and alpha =
0.05). The secondary datasets cover the entire population of interest--heart failure
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Medicare beneficiaries 65 years and over from 50 US states. There were no discrepancies
in the data noted. Nonapplicable data were excluded to segregate the subpopulation of
heart failure Medicare beneficiaries’ mortality and readmission rates.
Baseline Characteristics, Population Representativeness
Table 2 presents the descriptive statistics concerning the study population. The
analysis looked at heart failure prevalence (independent variable) and the mortality and
readmission rates (dependent variables) of Medicare patients 65 years of age and above.
The N for each year is 53 (rather than 50 states) because some U.S. territories such as the
Virgin Islands are included in the data.
Table 2
Means and Medians of Heart Failure Prevalence, Readmission Rates, and Mortality
Year

Heart Failure

Readmission Rates (%) Mortality (Count)

Prevalence (%)
Mean

Median

(SD)
2015
(N = 53)

12.2 (1.8)

Mean

Median

(SD)
12.0

23.5 (2.1)

Mean

Median

(SD)
23.7

17,399
(15,911)

13,999
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2016

12.2 (1.8)

12.2

23.5 (2.1)

24.1

20,894

(24,645)

(N=53)
2017

25,813.2

12.1 (1.9)

12.2

23.8 (2.2)

(N=53)

24.0

18,030.2

12,166

(17,874)

The information utilized in the CMS Chronic Conditions Data Warehouse reports
over the three years (2015, 2016, 2017) is based upon claims data and administrative
enrollment within CMS for Medicare recipients registered in the fee-for-service system
(“Chronic Conditions,” 2020). Every Medicare recipient’s status and age are data item as
recorded is the actual value as of the last day of the year concluded based on a value at the
end of the year (“Data Sources and Methodology,” 2020). Utilizing eligibility and claims
data allows the researcher to analyze death and readmission rates without needing to
examine medical charts or asking hospitals for additional data. The mortality and
readmission measures incorporate hospitalizations for Medicare recipients over the age of
65 who were registered in Original Medicare 1 year prior to their hospital admittance.
When concerning readmission rates, measures involved Medicare recipients 65 and over
registered in Original Medicare for 30 days following their initial admittance
(“Readmission and Death Measures,” 2020).
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Study Results
This subsection includes the statistical assumptions, research questions, results of
the statistical analysis findings, hypotheses test results, answers to the research questions,
and concludes with a summary of the study results.
Statistical Assumptions
The reason for using Pearson’s correlation is to determine the degree of
relationship that occurs between two variables. The assumptions for its use are that the two
variables must be continuous, there is a linear relationship between them, no significant
outliers are evident, and the variables must be approximately normally distributed (Laerd
Statistics, n.d.a). Assumptions for using multiple regression analysis are that the dependent
variable should be measured on a dichotomous scale, there is at least one continuous
independent variable, independence of observations must exist, a linear relationship exists
between the dependent and independent variables, there must be mutually exclusive
dependent variables; and the data must display homoscedasticity (Laerd Statistics, n.d.b).
For this study, the statistical assumptions were met and correlational and multiple
regression analysis were conducted and analyzed.
Research Questions
RQ1: Is there a relationship between the Medicare-covered services for care and
mortality rates of patients 65 years and over with heart failure?
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H1: There is no relationship between Medicare-covered services for care
and mortality of patients 65 years and over with heart failure.
H1: There is a relationship between Medicare-covered services for care and
mortality of patients 65 years and over with heart failure.
RQ2: Is there a relationship between Medicare-covered services for care and
readmission rates of patients 65 years and over with heart failure?
H2: There is no relationship between the Medicare-covered services for
care and readmission rates of patients 65 years and over with heart failure.
H2: There is a relationship between Medicare-covered services for care and
readmission rates of patients 65 years and over with heart failure.
Results of Correlational Analysis
Correlational analysis was conducted using SPSS version 25. Analysis in SPSS
was run using the Analyze>Correlate>Bivariate graphical user interface menu and syntax.
Publicly available CMS data for the years 2015, 2016 and 2017 were utilized in this
analysis. Variables under study were Medicare heart failure prevalence, heart failure 30day readmission, and heart failure mortality. Pearson correlation analysis was conducted
between Medicare heart failure prevalence and 30-day readmission for each year and
between Medicare heart failure prevalence and mortality.
As shown in Table 3, a statistically significant positive correlation was found
between Medicare heart failure prevalence and heart failure 30-day readmission for 2015
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and 2016 indicating that as Medicare heart failure prevalence increases, heart failure
readmission rates also increase for both years 2015 and 2016. Though there is a positive
association for the year 2017, the association is not statistically significant. Conventional
thresholds for interpreting the size of a correlation coefficient are values below 0.3 indicate
a weak correlation; values ranging from 0.3-0.7 indicate a moderate correlation; values
>0.7 indicate a strong correlation (Ratner, 2009). A correlation cannot exceed 1 (Ratner,
2009).
Table 3
Pearson Correlational Analyses Between Variables by Year for the Association Between
Heart Failure Prevalence and 30-Day Readmission
Year

Variable (X)

Variable (Y)

Correlation

P-value

Coefficient
2015

2016

2017

Heart Failure

Heart Failure 30-Day

Prevalence

Readmission

Heart Failure

Heart Failure 30-Day

Prevalence

Readmission

Heart Failure

Heart Failure 30-Day

Prevalence

Readmission

0.42

0.0017

0.48

0.0003

0.25

0.0711
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According to Table 4, a statistically significant positive correlation between
Medicare heart failure prevalence and heart failure mortality for the years 2015, 2016 and
2017 indicating that as Medicare heart failure prevalence increases, heart failure mortality
numbers also increase for years 2015, 2016 and 2017.
Table 4
Pearson Correlational Analyses Between Variables by Year for the Association Between
Heart Failure Prevalence and Mortality
Year

Variable (X)

Variable (Y)

Correlation

P-value

Coefficient
2015

2016

2017

Heart Failure

Heart Failure

Prevalence

Mortality

Heart Failure

Heart Failure

Prevalence

Mortality

Heart Failure

Heart Failure

Prevalence

Mortality

0.48

0.0003

0.46

0.0006

0.47

0.0004

1. The heart failure mortality presented in this study is not limited to a 30-day period.
Mortality data for the 30-day period is sparsely reported in the dataset U.S. States
and not reliable.
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Results of Multiple Regression Analysis
Publicly available CMS data for the years 2015, 2016 and 2017 were utilized in
this analysis. Regression analysis was conducted using the Analyze>Regression>Linear
graphical user interface menu and syntax. Variables were Medicare heart failure
prevalence, heart failure 30-day readmission, and heart failure mortality. The multiple
regression analyses were conducted between Medicare heart failure prevalence and heart
failure 30-day readmission for each year. The second set of multiple regression analyses
examined the association between Medicare heart failure prevalence and mortality. The
predictor variable was assumed to be Medicare heart failure prevalence and the outcome
variable is heart failure mortality.
This regression analysis predicts 30-day readmission for Medicare heart failure (Y,
denoting the outcome variable). The single predictor is heart failure prevalence (X,
denoting the predictor variable). As shown in Table 5, in 2015, higher heart failure
prevalence is associated with greater 30-day readmission rates (regression coefficient
b=0.48, p=0.002). Since the regression coefficient is 0.48, this means that on average a 1unit increase in the heart failure prevalence rate corresponds to an average 0.48 increase in
30-day readmission for heart failure, and this association is statistically significant
(p=0.002). For 2016, higher heart failure prevalence is associated with greater 30-day
readmission rates (regression coefficient b=0.57, p=0.001). Since the regression coefficient
is 0.57, this means that on average a 1-unit increase in the heart failure prevalence rate
corresponds to an average 0.57 increase in 30-day readmission for heart failure and this
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association is statistically significant (p=0.001). The association between the two variables
is not statistically significant for the year 2017 (p=0.071).
Table 5
Regression Analysis Between Variables by Year for the Association Between Heart Failure
Prevalence and 30-Day Readmission
Year

Variable (X)

Variable (Y)

Regression Coefficient (95% CI)

Pvalue

2015

Heart Failure

Heart Failure

Prevalence

30-Day

0.48 (0.18-0.77)

0.002

0.57 (0.27-0.86)

0.001

0.29 (-0.02-0.61)

0.071

Readmission
2016

Heart Failure

Heart Failure

Prevalence

30-Day
Readmission

2017

Heart Failure

Heart Failure

Prevalence

30-Day
Readmission

The second set of multiple regression analysis predicts mortality due to heart
failure (Y, denoting the outcome variable). The single predictor is Medicare heart failure
prevalence (X, denoting the predictor variable). As shown in Table 6, in 2015, higher heart
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failure prevalence is associated with greater mortality (regression coefficient b=4142.59,
p=0.001). Since the regression coefficient is 4,142.59, this indicates that, on average, a 1unit increase in the heart failure prevalence rate predicts an average 4,143 increase
mortality numbers for heart failure; this association is statistically significant (p=0.001). In
2016, higher heart failure prevalence is associated with greater mortality (regression
coefficient b=6248.10, p=0.001). Since the regression coefficient is 6,248.10, this indicates
that on average, a 1-unit increase in the heart failure prevalence rate predicts an average
6,248 increase in mortality numbers for heart failure; this association is statistically
significant (p=0.001). For 2017, higher heart failure prevalence is associated with greater
mortality (regression coefficient b=4468.74, p=0.001). Since the regression coefficient is
4,468.74, this indicates that on average, a 1-unit increase in the heart failure prevalence
rate corresponds to an average 4,469 increase in mortality numbers for heart failure; this
association is statistically significant (p=0.001).
Table 6
Regression Analysis Between Variables by Year for the Association Between Heart Failure
Prevalence and Mortality
Year

Variable (X)

Variable (Y)

Regression Coefficient (95% CI)

Pvalue

2015

Heart Failure

Heart Failure

Prevalence

Mortality

4,142.59 (1,991.94 - 6,293.25)

0.001
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2016

2017

Heart Failure

Heart Failure

Prevalence

Mortality

Heart Failure

Heart Failure

Prevalence

Mortality

6,248.10 (2,802.64 - 9,693.55)

0.001

4,468.74 (2,117.70 - 6,819.78)

0.001

1. The Heart failure mortality presented in this study is not limited to a 30-day period.
Mortality data for the 30-day period is sparsely reported in the dataset by the U.S. States
and not reliable.
Hypotheses Test Results
Research Question 1. The first research question asked if there is a relationship
between the Medicare-covered services for care and mortality rates of patients 65 years
and over with heart failure. Both correlational and multiple regression analyses determined
with a 95% confidence interval that the independent variable, heart failure utilization of
Medicare, was significant in predicting the outcome variable, mortality of heart failure
Medicare patients 65 years and over. The predictive relationship was statistically
significant per correlational analysis for 2015, 2016, and 2017 (p value = 0.0003, 0.0006,
0.0004) per Table 4 and statistically significant per multiple regression analysis for 2015,
2016, and 2017 (p value = 0.001, 0.001, 0.001) as shown in Table 6 for mortality due to
heart failure for Medicare beneficiaries 65 years and over, as the p-values are below the
conventional threshold of .05. Therefore, there is a relationship between Medicare-covered
services for care and mortality for patients 65 and over with heart failure and the null
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hypothesis is rejected: Hₒ1: There is no relationship between Medicare-covered services
and mortality of patients 65 and over with heart failure.
Research Question 2. The second research question sought to determine if there is
a relationship between Medicare-covered services for care and readmission rates of
patients 65 years and over with heart failure. Both correlational and multiple regression
analyses determined with a 95% confidence interval that the independent variable, heart
failure Medicare utilization, was significant in predicting the outcome variable,
readmission rates of heart failure Medicare patients 65 years and over for 2015 and 2016.
The predictive relationship was statistically significant per correlational analysis for 2015
and 2016 (p value = 0.0017, 0.0003) as shown in Table 3 and statistically significant per
multiple regression analysis for 2015 and 2016 (p value = 0.002, 0.001) as shown in Table
5 for readmission rates due to heart failure for Medicare beneficiaries 65 years and over, as
the p-values are below the conventional threshold of .05. However, the relationship was
not predictive and not statistically significant for 2017 per correlational analysis (p value =
0.0711) per Table 3 and not statistically significant per multiple regression analysis for
2017 (p value = 0.071) per Table 5 for readmission rates due to heart failure for Medicare
beneficiaries 65 years and over, as the p-values are above the conventional threshold of
.05. Therefore, there is a relationship between Medicare-covered services for care and
readmission rates for patients 65 and over with heart failure for 2015 and 2016 and the null
hypothesis is rejected: Hₒ2: There is no relationship between Medicare-covered services
and readmission rates of patients 65 and over with heart failure.
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Answers to Research Questions
Research question one was answered in that utilization of Medicare does predict
mortality of patients 65 years and over with heart failure for 2015, 2016, and 2017.
Research question two was answered in that utilization of Medicare does predict
readmission rates of patients 65 years and over with heart failure for 2015 and 2016.
Summary
Section 3 contains the analytic results and findings of this doctoral study and
includes the data compilation plan; results of the descriptive, correlational analyses, and
multiple regression analyses of the hypotheses and research questions; and the important
findings. The study examined Chronic Conditions Datawarehouse data from 2015 to 2017
collected by CMS to determine if heart failure Medicare utilization was predictive of
mortality and readmission rates of heart failure patients 65 years and over.
Section 4 provides a comprehensive analysis and interpretation of the results and
findings of the study. This section includes comparison of findings to the peer-reviewed
literature, assessment and explanation of the findings within the context of CMM’s
framework limitations, recommendations, and conclusions relevant to the study.

Section 4: Application to Professional Practice and Implications for Social Change
The purpose of this quantitative study was to determine if there is a relationship
between Medicare-covered services for care, mortality rates, and readmission rates for
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beneficiaries 65 years and over with heart failure. Findings from both correlational and
multiple regression analyses revealed significant, predictive relationships of utilization of
Medicare and mortality for 2015, 2016, and 2017. The results also revealed significant,
predictive relationships of utilization of Medicare and readmission rates of patients 65
years and over with heart failure in 2015 and 2016. Conversely, findings from the
correlational and multiple regression analyses indicated no significant predictive
relationships between utilization of Medicare and readmission rates for 2017. Section 4
includes an interpretation of the findings, limitations of the study, recommendations for
further research, and implications for professional practice and social change.
Interpretation of the Findings
Heart failure Medicare utilization was a significant predictor of mortality for 2015,
2016, and 2017 for heart failure patients 65 years and over. Heart failure Medicare
utilization was also a significant predictor of readmission rates for 2015 and 2016.
However, utilization of Medicare was not a significant predictor of readmission rates in
2017 for heart failure patients 65 years and over. In the following subsections, the findings
of this study are compared with those in the literature and to CCM’s framework, which
was used to assess the quality of care.
Utilization of Medicare and Heart Failure Outcomes
One study found that Medicare insured the majority (90.9%) of heart failure
patients aged 65 years and older, and that individuals with Medicare had considerably
shorter durations of stay for heart failure hospitalizations when compared with individuals
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possessing other insurance coverages (Chen et al., 2013). In-hospital mortality for
Medicare individuals with heart failure dropped from 4.5% in 2001 to 3.3% in 2009.
Significant decreases in in-hospital mortality were also detected for Medicare adults aged
65 - 74 years and 75 years or older. Individuals possessing self-pay coverage, private
insurance, Medicaid, and Medicare had substantial drops in in-hospital mortality. Utilizing
a nationwide all-payer database of institution discharges within the US, the general
nationwide hospitalization rate of heart failure fell by a comparative 26.9% from 20012009. This drop is comparable in scale to the 29.5% drop for hospitalization rates for heart
failure detected in the population with Medicare from 1998 to 2008. Adults of standard
Medicare age (greater than or equal to 65 years old) had statistically significant decreases
over time in duration of stay during the period of the study. Elderly patients usually have
several comorbidities, and thus possibly additional chances to lessen length of stay (LOS)
through more rigorous utilization of expert nursing accommodations or more referrals to
hospice care, both of which have increased with Medicare over the past ten years. Even
though in-hospital mortality has reduced throughout the past ten years amongst Medicare
beneficiaries, 30-day mortality has gradually reduced as a result of an increased amount of
deaths that transpire the following discharge from heart failure hospitalization (Chen et al.,
2013).
Driscoll et al., 2016, examined Medicare claims data and found that of the
individuals admitted for heart failure, an outpatient visit did not occur for approximately
52% of individuals. Heart failure medical procedures require prompt check-up seven to ten
days after discharge (Driscoll et al., 2016). Most analyses of information from The
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Longitudinal Health and Retirement Study have reported that insurance coverage in nearelderly individuals is associated with a slower rate of health deterioration and reduced
mortality (Woolhandler & Himmelstein, 2017). Similarly, two US studies and one
Canadian study compared mortality trends across matched locations without and with
coverage expansions and reported that greater coverage was associated with lower
mortality (Woolhandler & Himmelstein, 2017).
Readmission Rates Among Heart Failure Patients 65 Years and Over
By the beginning of 2014, two thirds of hospitals were already penalized for excess
readmission rates (Chamberlain et al., 2018). As a result, health centers and hospitals
began to prioritize detecting heart failure patients with the highest risk of readmission and
authorizing preventative intervention and early risk stratification. Medicare beneficiaries
have higher readmission rates compared to individuals with private insurance and
Medicaid (Chamberlain et al., 2018). Medicare recipients with heart failure have the
highest readmission rates, with research indicating that 18% of six-month all-cause
readmission rates were due to heart failure. In a study examining administrative discharge
figures on 41,776 individuals admitted to 236 hospitals in New York State, there was a
declining trend in heart failure readmission rates from the lowermost income quartile to
the uppermost (Chamberlain et al., 2018). The authors also discovered that salary was a
statistically significant predictor of readmission, with lower salaries associated with a
greater likelihood of readmission (Chamberlain et al., 2018).
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Even though overall rates for heart failure hospitalization among Medicare
recipients decreased between 1998 and 2008, unexpected readmissions continue to be a
common occurrence, with approximately one in four patients readmitted within 30 days of
discharge. In a study analyzing Medicare heart failure claims from 2009-2012, only 1.4%
of hospitals had attained a 20% decrease in 30-day readmission rates by December of
2012. This percentage was similar to those from reports based on data from the Hospital
Compare database, in which only 2.6% of hospital sites attained a 20% relative decrease
from the periods of July 2006 to June 2009 vs. July 2009 to June 2012. These outcomes
for heart failure patients are reliable, with current information indicating that reductions in
overall readmission rates for fee-for-service Medicare recipients have been minimal,
despite financial incentives and increased efforts among health systems (Bergethon et al.,
2016).
Mortality Among Heart Failure Patients 65 Years and Over
A retrospective cohort study, conducted from 2002 – 2005, comprised of about 8
million Medicare beneficiary fee-for-service hospitalizations for heart failure, acute
myocardial infarctions, and pneumonia of patients 65 years and above. The retrospective
study reported a considerable surge in trends in 30-day post discharge mortality among
Medicare recipients admitted for heart failure. The declaration and execution of the
Hospital Readmission Reductions Program (HRRP) was linked with a substantial increase
in death rates within 30 days of release from the hospital among Medicare recipients who
were admitted for pneumonia and heart failure, but not for acute myocardial infarction.
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Even though 30-day post discharge death rates for heart failure was growing before the
HRRP implementation, this surge quickened following the declaration and execution of
the program. Additionally, post discharge death rates for pneumonia was steady before the
HRRP implementation but escalated after declaration and execution of the program. The
surge in mortality for pneumonia and heart failure were propelled primarily by patients
who were not admitted again within 30 days of release from the hospital. The authors state
that further research is required in order to find out if increased mortality for heart failure
patients are a result of the HRRP (Wadhera et al., 2018).
Chronic Care Model for Heart Failure
Though broad implementation of the Chronic Care Model has occurred globally for
managing chronic illness, few studies have examined its success in enhancing outcomes in
patients with heart failure (Ballo et al., 2018). A metanalysis established that CCM is
beneficial for heart failure patient care, but has considerable variations in success (Drewes
et al., 2012).
The CCM was independently linked to a 35% likely decrease in hospitalization for
heart failure (Ballo et al., 2018). After an initial admission for heart failure, no variations
were detected between the two categories (the control group and CCM group) in danger of
additional hospitalizations for heart failure. There was no substantial difference between
the control and the CCM group in regard to 30-day heart failure readmission rates after an
initial hospitalization. When urgent and planned hospitalizations for heart failure were
considered separately, CCM was linked to a pointedly greater rate of hospitalizations.
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Through multivariate analysis, it was established that CCM was linked to an 18% lower
risk of mortality. Remarkably, even after being admitted, heart failure patients in the CCM
group indicated a 16% lower risk of death compared to controls. Results indicated that
CCM patients had a lower risk of death, but an increased risk of being admitted to the
hospital for heart failure than a matched control populace. Previous studies, typically
conducted in hospitals, have reported that implementation of CCM for heart failure
patients with continuing cardiac issues could be beneficial, but there is variability in its
success (Ballo et al., 2018).
Limitations of the Study
Though this study contributes to the literature by identifying important
associations, it is important to note its limitations. First, as with most secondary datasets,
the data were not prospectively collected or designed and thus some important variables
are missing from the dataset. Specifically, it would have been useful to adjust for the
potential role of comorbidities such as history of hypertension and diabetes (Murad et al.,
2015). Regarding readmissions, prior admissions tend to influence 30-day readmission in
care for patients with heart failure (Hummel et al., 2014). These limitations should be
considered when interpreting the findings of this study.
The strength and generalizability of this study are that it utilizes CMS data which
covers beneficiaries' encounters with health care providers including procedures and
services received. CMS data is a reliable and valid source of data for research and medical
decision-making (Mahmoudi et al., 2015).
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Recommendations
The limitations of the study reveal possible areas for improvement for future
academic researchers. To extend the research, covariates such as diabetes and hypertension
could be included (Murad et al., 2015). Common non-cardiac comorbidities for older
adults with heart failure include diabetes mellitus, malnutrition, sleep apnea, cognitive
dysfunction, chronic kidney disease, anemia, depression, and arthritis. Not surprisingly,
some comorbid illnesses are associated with higher mortality in heart failure individuals 65
years and over, including depression, diabetes mellitus, chronic kidney disease, and
cerebrovascular disease, with comorbid cerebrovascular disease having the greatest
mortality rate (Murad et al., 2015). Furthermore, the research could be extended to focus
on the impact of socioeconomic variables, such as race/ethnicity and marital status, on
Medicare heart failure patients 65 years and over. Marital status and race are key
reasons that contribute to the probability of readmission in heart failure patients 65 years
and over (Damiani et al., 2015).
Implications for Professional Practice and Social Change
This section presents implications for professional practice and positive social
change pertinent to readmissions and mortality for Medicare heart failure patients 65 years
and over. Financial penalties are being placed upon hospitals for excess readmissions for
heart failure patients (up to 3% of Medicare payments) for a year. Many hospitals are not
able to continue business when dealing with financial trials (supply costs and labor)
because profit status of the hospital is dependent upon hospital closures (Countouris et al.,
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2014). While financial penalties persist, this study can aid health care administrators in
recognizing some elements of hospital readmissions and mortality for heart failure patients
65 years and over.
Professional Practice
The results of this study indicate high mortality for heart failure patients 65 years
and over. Data indicates that transitional care interventions (nurse visits to patients’
homes) can decrease mortality rates and rates of readmission by over 30% for heart failure
patients 65 years and over. Numerous health organizations have not implemented such
plans. Experts in health policy state that non-implementation of the programs for
transitional care could be due to concerns regarding costs (Blum et al., 2020). Hospital
administrators can utilize the study to decide which transitional services are most costeffective for its hospital system, rural population, and overall patient base. High
readmission rates were also found in this study for Medicare heart failure patients 65 years
and over. Avoidable readmissions to the hospital cost Medicare over $15 billion yearly
(McHugh & Ma, 2013). Readmissions threaten the wellbeing of the frail, elderly who are
especially susceptible to functional loss, infections acquired within the hospital, and other
poor results once admitted to the hospital (McHugh & Ma, 2013). Pinpointing approaches
to decreasing avoidable hospitalization can be beneficial to healthcare administrators and
hospitals. A survey of preventative practices within hospitals and their impact on
decreasing 30-day heart failure readmission rates include partnering with health systems
and community physicians (Ziaeian, B. & Fonarow, 2016).
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Positive Social Change
As individuals age, incidence of heart failure increases, and prevalence of heart
failure is estimated to increase by 46% between 2012 to 2030 in the aging US population
(Jackson et al., 2018). Elderly heart failure adults have a 5-year mortality close to 50%
(Jackson et al., 2018). Mortality following a heart failure diagnosis has shown only small
improvement in the 21st century falling behind preventative practices employed with other
severe illnesses, such as cancer. Innovative approaches to attain well-timed identification
and treatment initiation for all socioeconomic populations must become a main concern for
upcoming research, healthcare administrators, and policymakers (Taylor et al., 2019).
Heart failure is the primary reason for hospitalizations among elderly adults and
heart failure Medicare recipients possess the highest rate of readmission of any illness
(Jackson et al., 2018). Through the Hospital Readmissions Reduction Program, specific
kinds of hospitals are more prone than others to receive penalties. These consist of
hospitals with comparatively greater amounts of low-income Medicare recipients and large
academic hospitals (Boccuti & Casillas, 2018). Congress passed legislation to include a
socioeconomic modification in the way hospital execution is assessed, centered on every
hospital’s number of inpatients who are dually eligible for full Medicaid and Medicare
(Boccuti & Casillas, 2018). The enactment of this approach must take into consideration
various important policy matters. A crucial question remains: How can care be improved
for patients with the highest health care needs, especially for patients admitted to the
hospital once or more in a year? An ongoing reduction in avoidable rates of readmission
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could aid in decreasing the rise in Medicare expenditure and could also indicate better care
for patients for the duration of their hospital stay (Boccuti & Casillas, 2018). Through
these methods, the implication for positive social change is maintaining and improving
access to care for all patients.
This study has provided clarity about utilization of Medicare, mortality rates, and
readmission rates of heart failure Medicare beneficiaries 65 years and over. The
relationship between these variables indicates a need for improved quality of care.
Therefore, as healthcare administrators develop understanding of the mortality and
readmission rates of Medicare heart failure beneficiaries, the strategies to be adapted for
decreasing mortality and readmissions of patients will ultimately result in improved
quality of care for patients.
Conclusion
This study identified if there is a relationship between Medicare-covered services
for care, mortality rates, and readmission rates for beneficiaries 65 years and over with
heart failure. Based on the findings of this study, it can be concluded that covariates and a
focus on the impact of socioeconomic variables on Medicare beneficiaries 65 years and
over with heart failure should be included for future research.
Overall, this study addressed the gap regarding the impact of the utilization of
Medicare on mortality rates and readmission rates of beneficiaries over the age of 65 with
heart failure. The study concluded significant, predictive relationships of utilization of
Medicare and mortality for 2015, 2016, and 2017. The results also revealed significant,
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predictive relationships of utilization of Medicare and readmission rates of patients 65
years and over with heart failure in 2015 and 2016. Healthcare administrators can utilize
the results of this study to concentrate on developing approaches that decrease avoidable
hospitalization and finding innovative approaches to attain well-timed identification and
treatment initiation for all socioeconomic groups. Finally, the Chronic Care Model’s
conceptual framework was utilized as the theoretical foundation and used to comprehend
the quality of care provided to heart failure patients.
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